Core Viewpoint - Haida Group (002311) has announced a three-year dividend return plan for 2025-2027, committing to a cash dividend ratio of no less than 30% [1] Group 1: Dividend Policy - The annual profit distribution plan will balance sustainable development, long-term maximization of shareholder value, and reasonable returns for investors [1] - The company will prioritize cash dividends as the method of profit distribution [1] - Each year, the profit distribution plan will be determined based on the current operational situation and project investment funding needs [1]

Core Viewpoint - The announcement details the verification and public disclosure of the reserved grant portion of the 2024 stock option incentive plan for Shandong Bangji Technology Co., Ltd, confirming that all listed incentive objects meet the necessary legal and regulatory qualifications [1][2][3] Disclosure Situation - The company publicly announced the list of incentive objects and provided a 10-day period for employees to raise any objections regarding the proposed incentive recipients [1] - No objections were received from employees by the end of the public disclosure period [2] Supervisory Board Verification Opinion - The supervisory board conducted a verification of the incentive object list according to relevant regulations and confirmed that all individuals listed meet the qualifications set forth by the Company Law and other applicable regulations [2] - The verification process ensured that none of the listed individuals had been deemed inappropriate candidates by the securities exchange or the China Securities Regulatory Commission within the last 12 months, nor had they faced any significant legal penalties [2][3] - The supervisory board concluded that all individuals on the incentive object list are legally and effectively qualified to participate in the stock option incentive plan [3]

Meeting Overview - The shareholder meeting was held on May 21, 2025, with voting conducted through both on-site and online platforms [1] - A total of 288,554,215 shares were represented, accounting for 20.1356% of the company's total shares [1] Voting Results - Proposal 4 received 278,596,336 votes in favor, representing 99.8915% of the valid votes [2] - Proposal 5 received 278,575,636 votes in favor, representing 99.8999% of the valid votes [2] - Proposal 6 received 278,676,336 votes in favor, representing 99.8934% of the valid votes [2] - Proposal 7 received 278,545,936 votes in favor, representing 99.9601% of the valid votes [2] Minority Shareholder Voting - Among minority shareholders, 19,348,288 shares voted in favor of the proposals, accounting for 65.9079% of the valid votes [3] - The company announced that there would be no cash dividends, stock bonuses, or capital increases from reserves for the 2024 fiscal year [3] Related Shareholder Abstentions - Related shareholder Hunan Tangrenshen Holdings Co., Ltd. abstained from voting on certain proposals [4][5][6] - The voting results for various proposals showed a consistent trend of majority support from minority shareholders, with percentages around 64.67% to 66.39% in favor [5][15] Legal Compliance - The meeting was attended by lawyers from Hunan Yixing Law Firm, who confirmed that the meeting complied with relevant laws and regulations [16][17]

证券代码：603363 证券简称：*ST 傲农 公告编号：2025-029 福建傲农生物科技集团股份有限公司 关于公司股票可能被终止上市的第五次风险提示公 告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 福建傲农生物科技集团股份有限公司（以下简称"公司"）于 2024 年 市风险警示及其他风险警示暨停牌的公告》（公告编号：2024-110）。因公司 且容诚会计师事务所（特殊普通合伙）对公司 2023 年年度财务报告出具了对持 续经营能力带强调事项段的无保留意见审计报告，公司股票已于 2024 年 5 月 6 日起被叠加实施其他风险警示。如果公司 2024 年度仍然存在《上海证券交易所 股票上市规则》中规定的不符合申请撤销股票交易退市风险警示的情形，公司 股票面临被终止上市的风险。敬请广大投资者注意投资风险。 公告》（公告编号：2025-014）。2025 年 2 月 14 日，公司披露了《关于公司股 票可能被终止上市的第二次风险提示公告》（公告编号：2025-021）。2025 年 2 月 28 日，公 ...